 Nephrosis, Lipoid
"Nephrosis, Lipoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A kidney disease with no or minimal histological glomerular changes on light microscopy and with no immune deposits. It is characterized by lipid accumulation in the epithelial cells of KIDNEY TUBULES and in the URINE. Patients usually show NEPHROTIC SYNDROME indicating the presence of PROTEINURIA with accompanying EDEMA.
| Descriptor ID |
D009402
|
| MeSH Number(s) |
C12.777.419.630.477 C13.351.968.419.630.477
|
| Concept/Terms |
Nephrosis, Lipoid- Nephrosis, Lipoid
- Lipoid Nephroses
- Lipoid Nephrosis
- Nephroses, Lipoid
- Minimal Change Glomerulopathy
- Minimal Change Disease
- Change Diseases, Minimal
- Disease, Minimal Change
- Diseases, Minimal Change
- Minimal Change Diseases
- Nephropathy, Minimal Change
- Minimal Change Nephropathies
- Minimal Change Nephropathy
- Nephropathies, Minimal Change
- Glomerulopathy, Minimal Change
- Glomerulopathies, Minimal Change
- Idiopathic Minimal Change Nephrotic Syndrome
Glomerulonephritis, Minimal Change- Glomerulonephritis, Minimal Change
- Glomerulonephritides, Minimal Change
- Minimal Change Glomerulonephritides
- Minimal Change Glomerulonephritis
|
Below are MeSH descriptors whose meaning is more general than "Nephrosis, Lipoid".
Below are MeSH descriptors whose meaning is more specific than "Nephrosis, Lipoid".
This graph shows the total number of publications written about "Nephrosis, Lipoid" by people in this website by year, and whether "Nephrosis, Lipoid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2018 | 0 | 1 | 1 | | 2021 | 1 | 0 | 1 | | 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Nephrosis, Lipoid" by people in Profiles.
-
Cara-Fuentes G, Verma R, Venkatareddy M, Bauer C, Piani F, Aksoy ST, Vazzalwar N, Garcia GE, Banks M, Ordo?ez FA, de Lucas-Collantes C, Bjornstad P, Gonz?lez Rodr?guez JD, Johnson RJ, Garg P. ?1-Integrin blockade prevents podocyte injury in experimental models of minimal change disease. Nefrologia (Engl Ed). 2024 Jan-Feb; 44(1):90-99.
-
Campbell RE, Thurman JM. The Immune System and Idiopathic Nephrotic Syndrome. Clin J Am Soc Nephrol. 2022 12; 17(12):1823-1834.
-
Trachtman H, Laskowski J, Lee C, Renner B, Feemster A, Parikh S, Panzer SE, Zhong W, Cravedi P, Cantarelli C, Kulik L, You Z, Satchell S, Rovin B, Liu F, Kalled SL, Holers VM, Jalal D, Thurman JM. Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome. Am J Physiol Renal Physiol. 2021 10 01; 321(4):F505-F516.
-
Cara-Fuentes G, Venkatareddy M, Verma R, Segarra A, Cleuren AC, Mart?nez-Ramos A, Johnson RJ, Garg P. Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse. Pediatr Nephrol. 2020 10; 35(10):1887-1896.
-
Rivard CJ, Tanabe T, Lanaspa MA, Watanabe H, Nomura S, Andres-Hernando A, Garth K, Sekijima M, Ishimoto T, Ariyoshi Y, Garcia GE, Shah J, Lennan B, Tasaki M, Pomposelli T, Shimizu A, Sachs DH, Johnson RJ, Yamada K. Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental study. Transpl Int. 2018 10; 31(10):1164-1177.
-
Cara-Fuentes G, Lanaspa MA, Garcia GE, Banks M, Garin EH, Johnson RJ. Urinary CD80: a biomarker for a favorable response to corticosteroids in minimal change disease. Pediatr Nephrol. 2018 07; 33(7):1101-1103.
-
Cara-Fuentes G, Segarra A, Silva-Sanchez C, Wang H, Lanaspa MA, Johnson RJ, Garin EH. Angiopoietin-like-4 and minimal change disease. PLoS One. 2017; 12(4):e0176198.
-
Cara-Fuentes G, Clapp WL, Johnson RJ, Garin EH. Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms. Pediatr Nephrol. 2016 12; 31(12):2179-2189.
-
Garin EH, Reiser J, Cara-Fuentes G, Wei C, Matar D, Wang H, Alachkar N, Johnson RJ. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis. Pediatr Nephrol. 2015 Mar; 30(3):469-77.
-
Cara-Fuentes G, Wasserfall CH, Wang H, Johnson RJ, Garin EH. Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis? Pediatr Nephrol. 2014 Dec; 29(12):2333-40.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|